rs2483205

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_174936.4(PCSK9):​c.658-7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.436 in 1,612,178 control chromosomes in the GnomAD database, including 154,963 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 15442 hom., cov: 34)
Exomes 𝑓: 0.43 ( 139521 hom. )

Consequence

PCSK9
NM_174936.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00001414
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:19

Conservation

PhyloP100: -0.272

Publications

36 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 1-55052643-C-T is Benign according to our data. Variant chr1-55052643-C-T is described in ClinVar as Benign. ClinVar VariationId is 36672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.658-7C>T
splice_region intron
N/ANP_777596.2
PCSK9
NM_001407240.1
c.781-7C>T
splice_region intron
N/ANP_001394169.1A0AAQ5BGX4
PCSK9
NM_001407241.1
c.658-7C>T
splice_region intron
N/ANP_001394170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.658-7C>T
splice_region intron
N/AENSP00000303208.5Q8NBP7-1
PCSK9
ENST00000710286.1
c.1015-7C>T
splice_region intron
N/AENSP00000518176.1A0AA34QVH0
PCSK9
ENST00000713786.1
c.781-7C>T
splice_region intron
N/AENSP00000519088.1A0AAQ5BGX4

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
67804
AN:
152030
Hom.:
15440
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.490
Gnomad AMI
AF:
0.600
Gnomad AMR
AF:
0.378
Gnomad ASJ
AF:
0.495
Gnomad EAS
AF:
0.224
Gnomad SAS
AF:
0.431
Gnomad FIN
AF:
0.468
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.445
Gnomad OTH
AF:
0.433
GnomAD2 exomes
AF:
0.419
AC:
104152
AN:
248680
AF XY:
0.425
show subpopulations
Gnomad AFR exome
AF:
0.489
Gnomad AMR exome
AF:
0.319
Gnomad ASJ exome
AF:
0.501
Gnomad EAS exome
AF:
0.218
Gnomad FIN exome
AF:
0.463
Gnomad NFE exome
AF:
0.449
Gnomad OTH exome
AF:
0.421
GnomAD4 exome
AF:
0.434
AC:
634366
AN:
1460030
Hom.:
139521
Cov.:
72
AF XY:
0.436
AC XY:
316773
AN XY:
726170
show subpopulations
African (AFR)
AF:
0.496
AC:
16593
AN:
33466
American (AMR)
AF:
0.323
AC:
14447
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.506
AC:
13196
AN:
26094
East Asian (EAS)
AF:
0.234
AC:
9289
AN:
39678
South Asian (SAS)
AF:
0.446
AC:
38460
AN:
86180
European-Finnish (FIN)
AF:
0.454
AC:
23882
AN:
52614
Middle Eastern (MID)
AF:
0.465
AC:
2683
AN:
5766
European-Non Finnish (NFE)
AF:
0.441
AC:
489957
AN:
1111220
Other (OTH)
AF:
0.429
AC:
25859
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
21634
43268
64903
86537
108171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14750
29500
44250
59000
73750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.446
AC:
67847
AN:
152148
Hom.:
15442
Cov.:
34
AF XY:
0.444
AC XY:
33048
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.490
AC:
20322
AN:
41512
American (AMR)
AF:
0.378
AC:
5783
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.495
AC:
1717
AN:
3472
East Asian (EAS)
AF:
0.223
AC:
1152
AN:
5158
South Asian (SAS)
AF:
0.430
AC:
2076
AN:
4826
European-Finnish (FIN)
AF:
0.468
AC:
4961
AN:
10602
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.445
AC:
30224
AN:
67972
Other (OTH)
AF:
0.430
AC:
908
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
2010
4020
6030
8040
10050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.447
Hom.:
43619
Bravo
AF:
0.439
Asia WGS
AF:
0.337
AC:
1177
AN:
3478
EpiCase
AF:
0.455
EpiControl
AF:
0.456

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Hypercholesterolemia, familial, 1 (5)
-
-
5
not specified (5)
-
-
4
Hypercholesterolemia, autosomal dominant, 3 (4)
-
-
2
Familial hypercholesterolemia (2)
-
-
2
not provided (2)
-
-
1
Hypobetalipoproteinemia (1)
-
1
-
Short fetal femur length (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.1
DANN
Benign
0.56
PhyloP100
-0.27
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000014
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2483205; hg19: chr1-55518316; COSMIC: COSV56162583; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.